3-(4-(4-methoxythiophen-3-yl)-1H-1,2,3-triazol-1-yl)piperidine-2,6-dione

ID: ALA5089479

PubChem CID: 151861511

Max Phase: Preclinical

Molecular Formula: C12H12N4O3S

Molecular Weight: 292.32

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  COc1cscc1-c1cn(C2CCC(=O)NC2=O)nn1

Standard InChI:  InChI=1S/C12H12N4O3S/c1-19-10-6-20-5-7(10)8-4-16(15-14-8)9-2-3-11(17)13-12(9)18/h4-6,9H,2-3H2,1H3,(H,13,17,18)

Standard InChI Key:  SKUSCUALKIOIST-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 20 22  0  0  0  0  0  0  0  0999 V2000
    7.4253   -4.9113    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.4253   -4.0863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7131   -3.6760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7131   -2.8510    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4253   -2.4406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0009   -4.0863    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.9124   -4.9086    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1105   -5.0759    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6960   -4.3638    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8778   -4.2794    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3276   -4.8885    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5729   -4.5568    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    2.6614   -3.7387    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4674   -3.5630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7992   -2.8125    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3170   -2.1464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2462   -3.7506    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1375   -3.6760    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.1375   -2.8510    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8539   -2.4406    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 10 14  1  0
 14 15  1  0
 15 16  1  0
  9 17  2  0
  6 17  1  0
  2 18  1  0
 18 19  1  0
  5 19  1  0
 19 20  2  0
M  END

Alternative Forms

1. Parent:

   

   ALA5089479

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 292.32

Molecular Weight (Monoisotopic): 292.0630

AlogP: 0.99

#Rotatable Bonds: 3

Polar Surface Area: 86.11

Molecular Species: NEUTRAL

HBA: 7

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 7

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 11.56

CX Basic pKa: ┄

CX LogP: 0.77

CX LogD: 0.77

Aromatic Rings: 2

Heavy Atoms: 20

QED Weighted: 0.85

Np Likeness Score: -0.88

References

1. Teng M, Lu W, Donovan KA, Sun J, Krupnick NM, Nowak RP, Li YD, Sperling AS, Zhang T, Ebert BL, Fischer ES, Gray NS..  (2022)  Development of PDE6D and CK1α Degraders through Chemical Derivatization of FPFT-2216.,  65  (1.0): [PMID:34965125] [10.1021/acs.jmedchem.1c01832]

2. Zimmermann, Gunther G and 8 more authors.  2014-06-26  Structure guided design and kinetic analysis of highly potent benzimidazole inhibitors targeting the PDEδ prenyl binding site.  [PMID:24884780]

3. Cheng, Junfei; Li, Yu; Wang, Xu; Dong, Guoqiang and Sheng, Chunquan.  2020-07-23  Discovery of Novel PDEδ Degraders for the Treatment of KRAS Mutant Colorectal Cancer.  [PMID:32603594]

Source

Source(1):

• Scientific Literature